U.S., July 23 -- ClinicalTrials.gov registry received information related to the study (NCT07076238) titled 'A Single-Center Observational Biomarker Investigation of Response to Bacteriophage Treatment for Bacterial Infection' on July 14.
Brief Summary: This study aims to identify biomarkers associated with response to phage therapy for refractory bacterial infections. Blood and leftover and/or discarded airway samples will be obtained from follow up visits of patients with refractory bacterial infections that are considered for phage therapy. Samples will be compared between those that receive phage therapy and those that did not. Biomarkers will include neutralizing antibody against phages, inflammatory cytokines, transcriptome and micro...